Notably, one reported case described successful treatment of anti-p200 pemphigoid in a patient with concomitant plaque psoriasis, suggesting that IL-23 inhibition may play a therapeutic role even in subepidermal autoimmune blistering diseases typically resistant to conventional immunosuppression [58]. This evidence concerns the gene IL23A and autoimmune bullous skin disease.